» Articles » PMID: 22821942

Coronary Microvascular Dysfunction Induced by Primary Hyperparathyroidism is Restored After Parathyroidectomy

Overview
Journal Circulation
Date 2012 Jul 24
PMID 22821942
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Symptomatic primary hyperparathyroidism (PHPT) is associated with increased cardiovascular mortality. However, data on the association between asymptomatic PHPT and cardiovascular risk are lacking. We assessed coronary flow reserve (CFR) as a marker of coronary microvascular function in asymptomatic PHPT of recent onset.

Methods And Results: We studied 100 PHPT patients (80 women; age, 58±12 years) without cardiovascular disease and 50 control subjects matched for age and sex. CFR in the left anterior descending coronary artery was detected by transthoracic Doppler echocardiography, at rest, and during adenosine infusion. CFR was the ratio of hyperemic to resting diastolic flow velocity. CFR was lower in PHPT patients than in control subjects (3.0±0.8 versus 3.8±0.7; P<0.0001) and was abnormal (≤2.5) in 27 patients (27%) compared with control subjects (4%; P=0.0008). CFR was inversely related to parathyroid hormone (PTH) levels (r=-0.3, P<0.004). In patients with CFR ≤2.5, PTH was higher (26.4 pmol/L [quartiles 1 and 3, 16 and 37 pmol/L] versus 18 [13-25] pmol/L; P<0.007), whereas calcium levels were similar (2.9±0.1 versus 2.8±0.3 mmol/L; P=0.2). In multivariable linear regression analysis, PTH, age, and heart rate were the only factors associated with CFR (P=0.04, P=0.01, and P=0.006, respectively). In multiple logistic regression analysis, only PTH increased the probability of CFR ≤2.5 (P=0.03). In all PHPT patients with CFR ≤2.5, parathyroidectomy normalized CFR (3.3±0.7 versus 2.1±0.5; P<0.0001).

Conclusions: PHPT patients have coronary microvascular dysfunction that is completely restored after parathyroidectomy. PTH independently correlates with the coronary microvascular impairment, suggesting a crucial role of the hormone in explaining the increased cardiovascular risk in PHPT.

Citing Articles

Parathyroid hormone-PTH1R signaling in cardiovascular disease and homeostasis.

Towler D Trends Endocrinol Metab. 2024; 35(7):648-660.

PMID: 38429163 PMC: 11233248. DOI: 10.1016/j.tem.2024.02.005.


Slow-Reflow and Prognosis in Patients with High Parathyroid Hormone Levels Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.

Wu G, Wu Z, Xu B, Chen S, Su W, Liu Y J Cardiovasc Transl Res. 2023; 17(3):657-668.

PMID: 37962823 DOI: 10.1007/s12265-023-10457-8.


Non-invasive coronary flow velocity reserve assessment predicts adverse outcome in women with unstable angina without obstructive coronary artery stenosis.

Montisci R, Marchetti M, Ruscazio M, Biddau M, Secchi S, Zedda N J Public Health Res. 2023; 12(2):22799036231181716.

PMID: 37333028 PMC: 10264896. DOI: 10.1177/22799036231181716.


Coronary Flow Velocity Reserve by Echocardiography: Beyond Atherosclerotic Disease.

Civieri G, Montisci R, Kerkhof P, Iliceto S, Tona F Diagnostics (Basel). 2023; 13(2).

PMID: 36673004 PMC: 9858233. DOI: 10.3390/diagnostics13020193.


Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion.

Tona F, Osto E, Kerkhof P, Montisci R, Famoso G, Lorenzoni G Eur J Clin Invest. 2021; 52(4):e13711.

PMID: 34780064 PMC: 9286413. DOI: 10.1111/eci.13711.